Belicose Pharmaceuticals Private Limited - Company Profile

It is a manufacturing private limited company based in Gaya, Bihar, India, established in 2017.
2017 Gaya, Bihar, India Struck Off
Last Updated:
About Belicose Pharmaceuticals Private Limited

Belicose Pharmaceuticals Private Limited, a struck off private limited company, was established on 24 August 2017 in Gaya, Bihar, India. Engaging in manufacturing within the manufacturing sector, it holds CIN: U36999BR2017PTC035517. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a active non-compliant status. Its leadership includes Rahul Kumar (Director), Kamlesh Sharma (Director). It is based at Lakhibag, Babhanbarui House, Manpur Laxmi Narayan Temple,, Gaya, Bihar, 823001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36999BR2017PTC035517

  • Registration Number

    035517

  • Incorporation Date

    24 August 2017

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Patna

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 8 Year, 6 Months
Company report

Belicose Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Belicose Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Belicose Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rahul Kumar Director 24 Aug 2017 Current
Kamlesh Sharma Director 24 Aug 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Belicose Pharmaceuticals.

Enhance accessibility to Belicose Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Belicose Pharmaceuticals revenue growth over time
Belicose Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Belicose Pharmaceuticals?

Unlock access to Belicose Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Belicose Pharmaceuticals?

Unlock and access historical data on people associated with Belicose Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Belicose Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Belicose Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Belicose Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Rahul Kumar was appointed as a Director was appointed as a Director on 24 Aug 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.

  • Director Appointment

    Kamlesh Sharma was appointed as a Director was appointed as a Director on 24 Aug 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.

  • Company Incorporation

    The activity Belicose Pharmaceuticals Private Limited was registered on 24 Aug 2017 with Roc Patna & aged 8 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Belicose Pharmaceuticals Private Limited?

The CIN of Belicose Pharmaceuticals Private Limited is U36999BR2017PTC035517.

Where is Belicose Pharmaceuticals Private Limited headquartered?

Belicose Pharmaceuticals Private Limited is headquartered at Lakhibag, Babhanbarui House, Manpur Laxmi Narayan Temple,, Gaya, Bihar, 823001.

When was Belicose Pharmaceuticals Private Limited incorporated?

Belicose Pharmaceuticals Private Limited was incorporated on 24 August 2017.

Who are the current directors of Belicose Pharmaceuticals Private Limited?

The current directors of Belicose Pharmaceuticals Private Limited are

What is the primary industry of Belicose Pharmaceuticals Private Limited?

The primary industry of Belicose Pharmaceuticals Private Limited is Manufacturing.

Is Belicose Pharmaceuticals Private Limited a listed company?

Belicose Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Belicose Pharmaceuticals Private Limited?

The authorized capital of Belicose Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Belicose Pharmaceuticals Private Limited?

The compliance status of Belicose Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available